US Sleep Apnea Devices Market

The market size for US sleep apnea devices is estimated to reach USD 3.11 billion by 2026 and is projected to grow to approximately USD 4.54 billion by 2031, at a CAGR of 7.8%. The rapid advancements in the diagnosis and treatment of sleep disorders are key factors driving this market growth. Innovations in CPAP machines are significantly contributing to the sleep apnea devices market. Additionally, the increasing number of diagnosed sleep disorders in the US and the growing demand for patient-centered devices are boosting the market for sleep apnea devices.

In May 2023, ResMed acquired Somnoware, a US-based company specializing in sleep and respiratory diagnostics. The acquisition strategy aims to enhance ResMed’s digital capabilities in sleep health. This will strengthen its portfolio by improving patient monitoring and diagnostics, further solidifying its position in the US sleep apnea devices and respiratory care markets.

To know about the assumptions considered for the study download the pdf brochure

In December 2023, Compumedics Limited, an Australian company, received US FDA product approval for its Somfit PSG Device. This approval allows Compumedics to market its Somfit home sleep testing devices in the US market, which the company has successfully launched.

The key players in this market are Philips (Netherlands), ResMed (US), Fisher & Paykel Healthcare (New Zealand), SomnoMed (Australia), Inspire Medical Systems (US), OpenAirway (Canada), Compumedics Limited (Australia), Löwenstein Medical SE & Co. KG (Germany), Drive DeVilbiss International (US), BMC (China), BRAEBON Medical Corporation (Canada), DynaFlex (US), Panthera Dental (Canada), Myerson LLC (US), ProSomnus Sleep Technologies (US), Nidek Medical India (India), Tomed GmbH (Germany), LivaNova PLC (UK), Invacare Holdings Corporation (US), MPowrx Health & Wellness Products Inc. (Canada), Nihon Kohden Corporation (Japan), SICAT GmbH & Co. KG (Germany), Vivos Therapeutics, Inc. (US), Airway Management (US), and Apnea Sciences (US).

ResMed, a leading company based in the US, has captured the largest share of the US sleep apnea devices market due to its innovative and effective diagnostic and therapeutic solutions. As a prominent player in healthcare technology and medical devices, ResMed offers sleep apnea devices that not only deliver accurate diagnostic results but also provide effective treatment for this serious medical condition. Over the years, ResMed has continually improved and expanded its range of sleep apnea devices, including positive airway pressure devices and facial interfaces, to ensure effective outcomes and high levels of customer satisfaction.

Koninklijke Philips N.V., based in the Netherlands, secured one of the highest market shares in the sleep apnea devices market in the US. Philips specializes in sleep health, and over time, it has become an important player in respiratory care and health monitor systems. The company is known for delivering excellent products with innovative features, such as ease of use, improving the quality of life for patients with sleep apnea. In recent years, Philips has expanded in the US and become better known to patients with sleep apnea through strategic partnerships and collaborations with healthcare providers, aiming to introduce people to sleep apnea devices and help them gain better knowledge about the condition.

Market Ranking

The key players in the US sleep apnea devices market have gained recognition for their comprehensive product offerings and continuous technological innovations. Some of the major players in the US sleep apnea devices market include Philips (Netherlands), ResMed (US), Fisher and Paykel Healthcare (New Zealand), and SomnoMed (Australia). ResMed and Fisher & Paykel Healthcare have gained recognition for offering sophisticated diagnostic and treatment equipment, including easy-to-use models for home and clinical use. Philips and SomnoMed maintain market leadership through their integrated sleep apnea diagnostic equipment, enabling quick, precise results and prompt diagnostic and clinical decision-making in both routine and emergency settings. Other notable contributors are expanding and enriching the market with their innovative equipment for workflow efficiency and healthcare quality. The key players have contributed significantly, increasing the reach of sleep apnea diagnostic and treatment equipment in the US market.

Related Reports:

US Sleep Apnea Devices Market by Product [Therapeutic {PAP (CPAP, APAP, BPAP), Oral Appliances, Masks}, Diagnostic {PSG, Home Sleep Testing, Oximeter}], Age, Gender, End User [Sleep Clinics, Hospitals, Home Care Settings] – Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com